📊 Evidence-Based Reference

modification to viabahn endoprosthesis

W.L. Gore & Associates

Summary: The modification to the Viabahn Endoprosthesis is a device used primarily for peripheral vascular interventions. Key evidence highlights its use in complex aortic and iliac aneurysm repairs.

FDA Clearance Information

Pathway 510K
Decision Date December 10, 2002
Product Code JCT
Device Class Class 2
Evidence 33 studies

The modification to the Viabahn Endoprosthesis was cleared by the FDA via the 510(k) pathway on December 10, 2002. It is manufactured by W.L. Gore & Associates and classified as a Class 2 device.

What It Is

The Viabahn Endoprosthesis is a stent graft used in endovascular procedures to treat peripheral vascular diseases. It is designed to provide a minimally invasive alternative to open surgical repair, particularly in complex vascular anatomies.

Clinical Applications

This device is commonly used in the treatment of aortic and iliac aneurysms, as well as in procedures requiring revascularization of peripheral arteries. It is particularly useful in scenarios where preserving blood flow to critical branches is necessary.

Evidence Summary

The literature includes 15 studies, comprising case series and other study types, published between 2014 and 2022. These studies explore various modifications and applications of the Viabahn Endoprosthesis in complex vascular procedures.

Reported Outcomes

Published studies report successful use of the Viabahn Endoprosthesis in complex aortic and iliac aneurysm repairs, with emphasis on its role in preserving branch vessel patency. Outcomes include effective revascularization and reduced procedural invasiveness.

Safety Profile

Reported complications include potential issues with stent graft stability and the need for precise deployment to avoid endoleaks. Some studies highlight the importance of operator experience in minimizing adverse events.

Evidence Limitations

The evidence is limited by the small sample sizes and the lack of long-term follow-up data in some studies. Further research is needed to establish standardized protocols and to assess long-term outcomes and safety.

Linked Studies (20)

PubMed • 2025

Popliteal Arteriovenous Fistula Diagnosed Eight Years after Total Knee Arthroplasty. Endovascular Treatment with Viabahn® Endoprosthesis and Five-Year Follow-Up.

Reports (MDPI)

Other View Source →
PubMed • 2024

Mid-Term Outcomes of the Viabahn Balloon-Expandable Endoprosthesis as Bridging Stent Graft for Fenestrated and Branched Endovascular Aortic Repair.

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2024

Laser Atherectomy and Restenting of the Superficial Femoral Artery Using GORE VIABAHN Endoprosthesis Following Failure of Both Bare-Metal Stenting and Surgical Revascularization.

Case reports in vascular medicine

View Source →
PubMed • 2024

Five-year outcomes of the GORE VIABAHN Endoprosthesis for the treatment of complex femoropopliteal lesions from a Japanese postmarket surveillance study.

Vascular medicine (London, England)

Prospective View Source →
PubMed • 2024

Three-Year Results of the GORE VIABAHN Endoprosthesis in the Superficial Femoral Artery for In-Stent Restenosis.

Journal of the Society for Cardiovascular Angiography & Interventions

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2024

Erratum: Three-Year Results of the GORE VIABAHN Endoprosthesis in the Superficial Femoral Artery for In-Stent Restenosis.

Journal of the Society for Cardiovascular Angiography & Interventions

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2024

Viabahn endoprosthesis for femoropopliteal aneurysm repair: safety, success rates, and long-term patency.

CVIR endovascular

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2023

FORWARD Study of GORE VIABAHN Balloon-Expandable Endoprostheses and Bare Metal Stents in the United States, European Union, United Kingdom, Australia, and New Zealand When Placed to Treat Complex Iliac Occlusive Disease: Protocol for a Randomized Superiority Trial.

JMIR research protocols

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2023

Use of real-world data and clinical registries to identify new uses of existing vascular endografts: combined use of GORE EXCLUDER Iliac Branch Endoprosthesis and GORE VIABAHN VBX Balloon Expandable Endoprosthesis.

BMJ surgery, interventions, & health technologies

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2022

Outcomes of Gore iliac branch endoprosthesis with internal iliac component versus Gore Viabahn VBX.

Journal of vascular surgery

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2022

Twelve-Month Outcomes From the Japanese Post-Market Surveillance Study of the Viabahn Endoprosthesis as Treatment for Symptomatic Peripheral Arterial Disease in the Superficial Femoral Arteries.

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2022

Individual patient data meta-analysis of patients treated with a heparin-bonded Viabahn in the femoropopliteal artery for chronic limb-threatening ischemia.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2021

Outcomes of chimney and fenestrated endografting using Viabahn VBX and atrium iCAST stents.

The Journal of cardiovascular surgery

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2021

Performance of the Gore VBX Balloon Expandable Endoprosthesis as Bridging Stent-Graft in Branched Endovascular Aortic Repair for Thoracoabdominal Aneurysms.

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2021

Bail-out technique to detach a locked Viabahn endoprosthesis in branched thoracic endovascular aortic repair.

Journal of vascular surgery cases and innovative techniques

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2020

First/Preliminary Experience of Gore Viabahn Balloon-Expandable Endoprosthesis as Bridging Stent in Fenestrated and Branched Endovascular Aortic Repair.

Annals of vascular surgery

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2015

Surgeon custom-made iliac branch device to salvage hypogastric artery during endovascular aneurysm repair.

Journal of Korean medical science

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2014

Transaortic modification of the Viabahn open revascularization technique (VORTEC) to facilitate renal artery revascularization in a hybrid EVAR procedure.

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2012

ViPS (Viabahn Padova Sutureless) technique: preliminary results in the treatment of peripheral arterial disease.

Annals of vascular surgery

Other View Source →
PubMed • 2012

New surgical and hybrid techniques for crural and pedal anastomoses.

The Journal of cardiovascular surgery

RCT|prospective|retrospective|case Series|other View Source →

Frequently Asked Questions

What are the clinical indications for modification to Viabahn Endoprosthesis?

The device is indicated for use in endovascular repair of peripheral vascular diseases, including aortic and iliac aneurysms.

What outcomes have been reported in clinical studies?

Studies report successful revascularization and preservation of branch vessel patency in complex vascular repairs.

What complications have been reported?

Safety data indicate potential complications such as stent graft instability and endoleaks, which require careful procedural planning.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 Stay Updated

Get the latest vascular education content delivered to your inbox.